Indivior PLC Proposes Re-Domiciliation to Delaware
I'm PortAI, I can summarize articles.
Indivior PLC announced plans to re-domicile from the U.K. to Delaware, U.S., establishing Indivior Pharmaceuticals, Inc. as the new holding company. This move aims to enhance U.S. capital market presence and simplify governance. Shareholders will vote on this proposal on December 11, 2025. If approved, Indivior Pharmaceuticals shares will replace Indivior shares on Nasdaq, aligning with the U.S.-based majority shareholder base.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments